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Letter to the Editor
Absence  of  legionellosis  in patients  with
community-acquired pneumonia  requiring
hospitalization
Dear Editor,
Community-acquired pneumonia (CAP) is associated with a
high morbi-mortality in the general population. The preva-
lence  of CAP varies between 8 and 15 cases per 1000
people, with higher prevalence in the extremes of age. In
the  USA, in 2005, there were  1.3 million hospitalizations due
to  pneumonia.1 Legionella spp. has been implicated in 1–5%
of  CAP cases.2 Despite the scarce reports on legionellosis in
Brazil,3,4 very limited data are available from cohort studies.5
In order to investigate the prevalence of legionellosis among
patients  with CAP, here we  report the results of a prospec-
tive  survey conducted in a 1200-bed tertiary Brazilian hospital,
between  October 2010 and July 2013.
Adult patients (>18 years old) with suspected CAP admit-
ted  to Santa Casa de Porto Alegre (Brazil) were  considered
for  inclusion in this study. CAP was  diagnosed in the pres-
ence  of a new lung inﬁltrate, and at least one of the following:
sputum production, fever higher than 38 ◦C, cough or abnor-
mal  breath sounds. In order to avoid the inclusion of patients
with  health care associated pneumonia, patients with a his-
tory  of hospitalization in the last three months were excluded.
After  consenting to participate in the study, a urine sam-
ple  was  obtained for Legionella urinary antigen test (BINAX
Inc.,  USA). A respiratory sample (sputum, tracheal aspirate or
bronchoalveolar lavage ﬂuid) was  also obtained for Legionella
real  time polymerase chain reaction (qPCR) testing (Nanogen
Inc.,  USA). DNA was  extracted using ExtraCell DNA Extrac-
tion  Kit (Nanogen Inc., USA). An internal extraction control
(CPE-DNA®) was  used to monitor for the presence of PCR
inhibitors. Medical records were reviewed to obtain data on
patients’  demographics, history of current disease, underly-
ing  diseases, smoking history, and antibiotic exposure in the
last  two weeks. Curb 65 and IDSA/ATS Pneumonia Severity
Index  for CAP were  used to evaluate the severity of CAP. The
study  was  approved by the ethics committees of participating
institutions.
A  total of 95 patients were  included (56.8% men). The mean
age  (±standard deviation, sd) was  61.7 ± 19.8 years. The most
common  co-morbidities were  high blood pressure (26.8%),
chronic  obstructive pulmonary disease (22.1%), and diabetesmellitus  (20.0%). Smokers represented 18.9% of the patients
(n  = 18) and additionally 22.1% (n = 21) were former smokers.
Median duration of symptoms at study inclusion was eight
days  (range, 1–60 days), 84 (88.4%) patients were  on antibi-
otics  and 35 were on empirical treatment for Legionella sp.
Twenty-nine patients fulﬁlled the IDSA/ATS criteria for severe
CAP,  including 17 who needed invasive mechanic ventilation.
According to Curb 65, 31.6% (n = 30) of the patients scored
≥2.  The PaO2/FiO2 ratio was  evaluated in 53 patients – mean
value  (±sd) was  240 ± 88. Ten (10.5%) patients needed ICU sup-
port.  The overall in-hospital mortality was  17.9% (n = 17). No
patient  was found to be infected by Legionella pneumophila in
this  study.
As  far as we are concerned this is the ﬁrst prospective
study performed in Brazil in which modern diagnostic tools
were  used to determine the prevalence of legionellosis in
patients  with CAP. The study was  originally conceived to com-
pare  two diagnostic tests in patients with legionellosis: urinary
antigen  test and qPCR in respiratory samples. Since all sam-
ples  tested negative for Legionella spp., this comparison was
obviously  not performed. qPCR test may  provide results in a
few hours, and has the potential to detect Legionella species
belonging to any of the serogroups. Since qPCR has simi-
lar  or higher sensitivity than sputum culture,1 qPCR has the
potential  to become the gold-standard for the diagnosis of
legionellosis.  The urinary antigen test has the advantage of
being  a fast (∼15 min) and highly sensitive (<95%) test. Regard-
less  of the diagnostic test being used – i.e., urinary antigen
or  qPCR – the main question appears to be: is legionellosis
really relevant in terms of frequency as a cause of CAP?
The  results of our study are indicative of a rather low fre-
quency.
The  main limitation of our study relies on being a single-
center study in which a limited number of patients were
included. Our results suggest that the frequency of legionel-
losis  in patients with CAP admitted to the hospital is too low to
justify widespread empirical coverage against Legionella spp.
Perhaps  legionellosis is mostly occurring in outbreaks. Con-
tinuous  surveillance and availability of data from additional
medical centers are ultimately required to understand the low
frequency of legionellosis found in our medical center.










(b r a z j i n f e c t d i s .
onﬂicts  of  interest
he authors declare no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
. American Thoracic Society. Trends in pneumonia and
inﬂuenza morbidity and mortality. American Thoracic Society;
2007.
. Diederen BMW, Kluytmans JAJW, Vandenbroucke-Grauls CM,
Peeters  MF. Utility of real-time PCR for diagnosis of
legionnaires’ disease in routinal clinical practice. J Clin
Microbiol. 2008;46:671–7.
. Porto NS, Palombini BC, Petrillo VF, Alves MRA. Pneumonia por
Legionella  pneumophila. Relato do segundo caso brasileiro. Rev
Inst  Bras Med Trop São Paulo. 1986;28:368–70.
.  Meira DA, Fabris VE, Arakaki D, Correia Filho D, Teixeira UA.
Pneumonia  por Legionella pneumophila com insuﬁciência
respiratória aguda e evoluc¸ão  fatal: relato de caso em Botucatu
São  Paulo. Arq Bras Med. 1993;67:25–7.
.  Mazieri NAO, Godoy CVF, Alves SF, et al. Legionnaires′ disease
in the renal transplant unit of ‘Hospital das Clínicas. FMUSP′.
During a ﬁve year period (1988–1993). Rev Inst Med Trop São
Paulo.  1994;36:231–6.uliana Kühne, Tiago S. Linhares
Universidade Federal de Ciências da Saúde de Porto Alegre
UFCSPA), Porto Alegre, RS, Brazil4;1 8(5):572–573  573
Huander F. Andreollaa,b
a Universidade Federal de Ciências da Saúde de Porto Alegre
(UFCSPA), Porto Alegre, RS, Brazil
b Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Ale-
gre,  RS, Brazil
Claudio M.B. Stadnik
Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre,
RS,  Brazil
Alessandro C. Pasqualottoa,b,∗
a Universidade Federal de Ciências da Saúde de Porto Alegre
(UFCSPA), Porto Alegre, RS, Brazil
b Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Ale-
gre,  RS, Brazil
∗ Corresponding author at: Molecular Biology Laboratory, Irman-
dade  Santa Casa de Misericórdia de Porto Alegre, Av
Independência 155, Porto Alegre 90430-020, Brazil.
E-mail addresses: pasqualotto@santacasa.tche.br,
pasqualotto@ufcspa.edu.br (A.C. Pasqualotto).
Received 1 March 2014
Accepted 10 May  2014
Available  online 5 June 2014
http://dx.doi.org/10.1016/j.bjid.2014.05.004
1413-8670/© 2014 Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND
